James Cassidy - Jan 5, 2023 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Chief Medical Officer
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Stock symbol
SWTX
Transactions as of
Jan 5, 2023
Transactions value $
-$34,758
Form type
4
Date filed
1/9/2023, 04:00 PM
Previous filing
Oct 11, 2022
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Award +22.7K +87.74% 48.5K Jan 5, 2023 Direct F1
transaction SWTX Common Stock Tax liability -$34.8K -1.26K -2.6% $27.52 47.2K Jan 6, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWTX Stock Option (Right to Buy) Award $0 +70K $0.00 70K Jan 5, 2023 Common Stock 70K $27.64 Direct F3
transaction SWTX Stock Option (Right to Buy) Award $0 +65K $0.00 65K Jan 5, 2023 Common Stock 65K $27.64 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 5, 2024, another thirty three percent (33%) to vest on January 5, 2025 and the remaining thirty four percent (34%) to vest on January 5, 2026, such that the restricted stock awards are fully vested on January 5, 2026.
F2 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
F3 This option shall vest in 48 equal monthly installments subject to continued service to the Issuer by the Reporting Person.
F4 Twenty-five percent (25%) of this option shall vest and become exercisable on January 5, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter subject to continued service to the Issuer by the Reporting Person.